Fatal progressive cerebral ischemia in CML under third-line treatment with ponatinib

被引：24
作者：
Mayer, K. [1 ]
Gielen, G. H. [2 ]
Willinek, W. [3 ]
Muller, M. C.
Wolf, D. [1 ]
机构：
[1] Univ Hosp Bonn, Med Clin 3 Oncol Haematol & Rheumatol, Bonn, Germany
[2] Univ Hosp Bonn, Inst Neuropathol, Bonn, Germany
[3] Univ Hosp Mannheim, Med Clin 3, Mannheim, Germany
来源：
LEUKEMIA | 2014年 / 28卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; ARTERIAL OCCLUSIVE DISEASE; NILOTINIB THERAPY; VASCULAR EVENTS; IMATINIB;
D O I：
10.1038/leu.2013.320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：976 / 977
页数：2
相关论文
共 8 条
  • [1] Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
    Aichberger, Karl J.
    Herndlhofer, Susanne
    Schernthaner, Gerit-Holger
    Schillinger, Martin
    Mitterbauer-Hohendanner, Gerlinde
    Sillaber, Christian
    Valent, Peter
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (07) : 533 - 539
  • [2] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
    Baccarani, Michele
    Deininger, Michael W.
    Rosti, Gianantonio
    Hochhaus, Andreas
    Soverini, Simona
    Apperley, Jane F.
    Cervantes, Francisco
    Clark, Richard E.
    Cortes, Jorge E.
    Guilhot, Francois
    Hjorth-Hansen, Henrik
    Hughes, Timothy P.
    Kantarjian, Hagop M.
    Kim, Dong-Wook
    Larson, Richard A.
    Lipton, Jeffrey H.
    Mahon, Francois-Xavier
    Martinelli, Giovanni
    Mayer, Jiri
    Mueller, Martin C.
    Niederwieser, Dietger
    Pane, Fabrizio
    Radich, Jerald P.
    Rousselot, Philippe
    Saglio, Giuseppe
    Saussele, Susanne
    Schiffer, Charles
    Silver, Richard
    Simonsson, Bengt
    Steegmann, Juan-Luis
    Goldman, John M.
    Hehlmann, Ruediger
    [J]. BLOOD, 2013, 122 (06) : 872 - 884
  • [3] Ponatinib in Refractory Philadelphia Chromosome-Positive Leukemias
    Cortes, Jorge E.
    Kantarjian, Hagop
    Shah, Neil P.
    Bixby, Dale
    Mauro, Michael J.
    Flinn, Ian
    O'Hare, Thomas
    Hu, Simin
    Narasimhan, Narayana I.
    Rivera, Victor M.
    Clackson, Tim
    Turner, Christopher D.
    Haluska, Frank G.
    Druker, Brian J.
    Deininger, Michael W. N.
    Talpaz, Moshe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22) : 2075 - 2088
  • [4] Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis
    Giles, F. J.
    Mauro, M. J.
    Hong, F.
    Ortmann, C-E
    McNeill, C.
    Woodman, R. C.
    Hochhaus, A.
    le Coutre, P. D.
    Saglio, G.
    [J]. LEUKEMIA, 2013, 27 (06) : 1310 - 1315
  • [5] Khoury HJ, 2013, J CLIN ONCOL S, V31
  • [6] Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
    Kim, T. D.
    Rea, D.
    Schwarz, M.
    Grille, P.
    Nicolini, F. E.
    Rosti, G.
    Levato, L.
    Giles, F. J.
    Dombret, H.
    Mirault, T.
    Labussiere, H.
    Lindhorst, R.
    Haverkamp, W.
    Buschmann, I.
    Doerken, B.
    le Coutre, P. D.
    [J]. LEUKEMIA, 2013, 27 (06) : 1316 - 1321
  • [7] Severe Peripheral Arterial Disease During Nilotinib Therapy
    Le Coutre, Philipp
    Rea, Delphine
    Abruzzese, Elisabetta
    Dombret, Herve
    Trawinska, Malgorzata M.
    Herndlhofer, Susanne
    Doerken, Bernd
    Valent, Peter
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (17) : 1347 - 1348
  • [8] Nilotinib-Associated Vascular Events
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Cortes, Jorge
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (05) : 337 - 340
1